[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 43,318
Sort by:

China Diagnostic Reagent Industry Report, 2013-2016

US$ 2,400.00

... . Especially, Mindray Medical and KHB achieved the respective in vitro diagnostics revenue of RMB2.0458 billion and RMB1.0572 billion in 2013, ... industry through acquisitions. The report covers the following: Status quo of China diagnostic reagent industry, including overview, market structure, import, ...

July 2014 140 pages

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

US$ 27,600.00

... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...

July 2014 1200 pages

2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

US$ 15,760.00

... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...

July 2014 820 pages

2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. French Market Overview Five-year test volume and sales ...

July 2014 585 pages

2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices

US$ 5,360.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. German Market Overview Five-year test volume and sales ...

July 2014 585 pages

2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Italian Market Overview Five-year test volume and sales ...

July 2014 570 pages

2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 7,040.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Japanese Market Overview Five-year test volume and sales ...

July 2014 590 pages

2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

July 2014 565 pages

2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs

US$ 5,360.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

July 2014 565 pages

2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

US$ 7,840.00

... be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... growing demand for malignancy assays and the rapid market expansion. US Market Overview Five-year test volume and sales projections ...

July 2014 620 pages

Cancer Immunotherapy Market & Clinical Pipeline Insight

US$ 3,000.00

... use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: Cancer Immunotherapy Market Overview Cancer Immunotherapy Market Dynamics Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country Cancer Vaccine Clinical ...

July 2014 1990 pages

Oncology Market Access Europe – Payer and Industry Perspectives

US$ 995.00

... experts from the UK, Germany, Italy, France and Spain, FirstWord’s Oncology Market Access Europe – Payer and Industry Perspectives lays out the current – and growing – challenges facing companies in getting drugs to the European market. Filled with compelling insight into the most pressing issues ranging ...

June 2014 75 pages

The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth

US$ 900.00

... growth rate can be attributed to an increasing number of drugs being approved by the United States Food and Drug Association along with the increasing ... held a market share of ~% and recorded sales of USD ~ million. The US Anti Cancer Drug Market is expected to grow over the period at a CAGR of 29.4% with ...

June 2014 144 pages

Global Molecular Diagnostics Market Report: 2014 Edition

US$ 800.00

... in the field of oncology and reimbursement trend. The report presents thorough analysis of the global molecular diagnostics market and its various segments and also provides ...

June 2014 59 pages

Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

US$ 19,600.00

Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. 'Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside' is Venture Planning Group's new seven- ...

June 2014 650 pages

Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer - Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

US$ 19,600.00

... tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ... of over 500 companies, universities and research centers developing new tumor markers and detection technologies. Competitive Assessments Extensive strategic assessments ...

June 2014 1200 pages

2014 Clinical Chemistry and Immunodiagnostic Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

US$ 9,200.00

... (test volumes, sales forecasts, supplier shares) $7,500. 2014 Clinical Chemistry and Immunodiagnostics Testing in US Hospitals, Commercial Laboratories and Point-of-Care ... suppliers. Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...

June 2014 635 pages

2014 Coagulation Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

US$ 9,200.00

... and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, ...

June 2014 455 pages

New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 6,800.00

New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, ...

June 2014 450 pages

New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 6,800.00

New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups ... hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...

June 2014 279 pages

New Frontiers in Point-of-Care/POC Infectious Disease Testing:Business Challenges, Emerging Technologies, Competitive Landscape

US$ 6,800.00

New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC infections disease testing market, including its dynamics, size, growth, regulatory ...

June 2014 835 pages

2014 Market Research Report on Global Blood Cell Separator Industry

US$ 2,850.00

'2014 Market Research Report on Global Blood Cell Separator Industry' was a professional and depth research report on Global Blood Cell Separator industry ... , cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, ...

June 2014 176 pages

2014 Market Research Report on Global Blood Component Separator Industry

US$ 2,850.00

'2014 Market Research Report on Global Blood Component Separator Industry' was a professional and depth research report on Global Blood Component Separator ... from Blood Component Separator industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...

June 2014 176 pages

2014 Market Research Report on Global Blood Irradiation Industry

US$ 2,850.00

'2014 Market Research Report on Global Blood Irradiation Industry' was a professional and depth research report on Global Blood Irradiation industry that you ... , cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, ...

June 2014 176 pages

2014 Market Research Report on Global Blood Sample Collection Needle Industry

US$ 2,850.00

'2014 Market Research Report on Global Blood Sample Collection Needle Industry' was a professional and depth research report on Global Blood Sample Collection ... cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, ...

June 2014 176 pages

2014 Market Research Report on Global General Fluoroscopy Industry

US$ 2,850.00

'2014 Market Research Report on Global General Fluoroscopy Industry' was a professional and depth research report on Global General Fluoroscopy industry that you ... cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, ...

June 2014 176 pages

Cancer Cytokines Therapy Pipeline Analysis

US$ 1,800.00

... are related to almost all the therapeutic protein drug development processes. The cytokine and growth factor related products include antibodies ... improve quality of life. “Cancer Cytokines Therapy Pipeline Analysis” Report Highlights: Cancer Cytokines Therapy Market Overview Marketed Drug Profiles & Patent ...

June 2014 231 pages

Cancer Cell Therapy Market & Pipeline Insight

US$ 2,400.00

... the spread of cancer. “Cancer Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: Cancer Cell Therapy Market Overview Cancer Cell Therapy Market Dynamics Clinical Pipeline by Phase, country & Target Indications Cancer Cell Therapy Drugs in Pipeline: 82 Highest Number of Drugs in Preclinical ...

June 2014 195 pages

New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 13,200.00

New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of theten POC market segments, including their dynamics, size, growth, regulatory requirements, ...

May 2014 1172 pages

New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape

US$ 10,000.00

New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, ...

May 2014 973 pages

New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 10,000.00

New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the physician office market segment, including dynamics, size, growth, regulatory requirements, technological ...

May 2014 970 pages

New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 10,000.00

New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, ...

May 2014 973 pages

Deals in Oncology Personalized Medicine Industry – Worldwide Analysis

US$ 900.00

The Personalized Medicine in Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals ...

May 2014 43 pages

Physician Views: How do oncologists value medical affairs teams – what could they be doing better?

US$ 695.00

... and value of these teams. FirstWord's latest Physician Views poll seeks to gain some insight into how physicians value the role that medical affairs personnel play. Specifically we asked US and EU5-based oncologists: How important they view ...

May 2014

New Frontiers in Hematology and Flow Cytometry: Global Challenges, Emerging Technologies, Competitive Landscape

US$ 27,360.00

Complete report $34,200.DataPack (test volumes, sales forecasts, supplier shares) $21,100. New Frontiers in Hematology and Flow Cytometry: Global Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new seven-country report designed to help current suppliers and potential ...

May 2014 700 pages

New Frontiers in European Hematology and Flow Cytometry Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 15,760.00

... .DataPack (test volumes, sales forecasts, supplier shares) $12,800. New Frontiers in European Hematology and Flow Cytometry Markets: Business Challenges, Emerging ... Analysis Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country. Specimen, test and sales ...

May 2014 450 pages

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

US$ 27,600.00

... $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,800. New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive ... emerging during the next five years. The report provides five-year volume and sales forecasts for over 100 clinical ...

May 2014 1115 pages

New Frontiers in the European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 15,760.00

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. New Frontiers in the European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new five-countrystrategic analysis of ...

May 2014 900 pages

New Frontiers in the French Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

... $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in the French Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, ... the nextfive years. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes, ...

May 2014 542 pages

New Frontiers in the German Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in theGerman Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

May 2014 578 pages

New Frontiers in the Italian Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in theItalian Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

May 2014 561 pages

New Frontiers in the Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 6,080.00

... 600. DataPack (test volumes, sales forecasts, supplier shares) $4,900. New Frontiers in the Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, ... the nextfive years. The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes, ...

May 2014 559 pages

New Frontiers in the Spanish Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in theSpanish Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

May 2014 568 pages

New Frontiers in the UK Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 4,880.00

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in the UK Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business opportunities ...

May 2014 563 pages

New Frontiers in the US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 9,200.00

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500. New Frontiers in theU.S. Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

May 2014 600 pages

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

US$ 27,600.00

Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new seven-country strategic analysis of the major business opportunities ...

May 2014 821 pages

New Frontiers in the European Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 15,880.00

Complete report $19,850. DataPack (test volumes, sales forecasts, supplier shares) $12,900. New Frontiers in the European Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new five-country strategic analysis of the major ...

May 2014 600 pages

New Frontiers in the French Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,560.00

... . DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in the French Automated Microbiology Market: Business Challenges, Emerging Technologies ... next five years. The report examines key trends in the French automated microbiology market; reviews current and emerging assays; analyzes ...

May 2014 423 pages

New Frontiers in the German Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,560.00

... . DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in the German Automated Microbiology Market: Business Challenges, Emerging Technologies ... next five years. The report examines key trends in the German automated microbiology market; reviews current and emerging assays; analyzes ...

May 2014 420 pages

New Frontiers in the Italian Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

US$ 5,560.00

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in the Italian Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging ...

May 2014 417 pages

Filters

Search

Categories

675
84
1,065
33,609
152
69
819
657
1,866
4,252
70

Publishers

1
8
9
36
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
45
11
78
1
14
2
22
3
74
41,216
1
40
2
17
15
24
85
6
10
51
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
16,410
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

34
6
1
15
84